The fate of hypoxic (pimonidazole-labelled) cells in human cervix tumours undergoing chemo-radiotherapy

Radiotherapy and Oncology

Volumn 80, Issue 2, 2006, Pages 138-142

  Durand, Ralph E ^a   Aquino Parsons, Christina ^b  

^a Department of Medical Biophysics ^*  (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Cervix; Chemo radiotherapy; Hypoxia; Pimonidazole; Predictive assays

Indexed keywords

BIOLOGICAL MARKER; CISPLATIN; PIMONIDAZOLE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIVISION; CELL FATE; CELL HYPOXIA; CELL LOSS; CELL PROLIFERATION; CELL SUSPENSION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA CONTENT; FEMALE; HALF LIFE TIME; HUMAN; HUMAN TISSUE; INFORMED CONSENT; LABORATORY TEST; PRIORITY JOURNAL; RADIOSENSITIVITY; TREATMENT OUTCOME; TUMOR BIOPSY; UTERINE CERVIX TUMOR;

ADULT; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; FEMALE; HUMANS; NITROIMIDAZOLES; OXYGEN; RADIATION-SENSITIZING AGENTS; SPHEROIDS, CELLULAR; UTERINE CERVICAL NEOPLASMS;

EID: 33748166092     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.07.022     Document Type: Article

References (24)

1. Aquino-Parsons C., Luo C., Vikse C.M., and Olive P.L. Comparison between the comet assay and the oxygen microelectrode for measurement of tumor hypoxia. Radiother Oncol 51 (1999) 179-185
2. Durand R.E. Use of Hoechst-33342 for cell selection from multicell systems. J Histochem Cytochem 30 (1982) 117-122
3. Durand R.E. Multicell spheroids as a model for cell kinetics studies. Cell Tissue Kinet 23 (1990) 141-159
4. Durand R.E. Contributions of flow cytometry to studies with multicell spheroids. In: Darzynkiewicz Z., Robinson J.P., and Crissman H.A. (Eds). Flow cytometry (1994), Academic Press, Orlando 405-422
5. Durand R.E., and Aquino-Parsons C. Non-constant tumour blood flow: implications for therapy. Acta Oncol 40 (2001) 862-869
6. Durand R.E., and Aquino-Parsons C. The clinical relevance of intermittent tumour blood flow. Acta Oncol 40 (2001) 929-936
7. Durand R.E., and Aquino-Parsons C. Predicting response to treatment in human cancers of the uterine cervix: sequential biopsies during external beam radiotherapy. Int J Radiat Oncol Biol Phys 58 (2004) 555-560
8. Durand R.E., Chaplin D.J., and Olive P.L. Cell sorting with Hoechst or carbocyanine dyes as perfusion probes in spheroids and tumors. In: Darzynkiewicz Z., and Crissman H.A. (Eds). Methods in cell biology vol. 33 (1990), Academic Press, San Diego 509-518
9. Durand R.E., and Olive P.L. Tumour cell kinetics and heterogeneity: insights from multicell spheroids. Br J Radiol 24 (1993) 79-83
10. Durand R.E., and Raleigh J.A. Identification of nonproliferating but viable hypoxic tumor cells in vivo. Cancer Res 58 (1998) 3547-3550
11. Franko A.J., and Sutherland R.M. Oxygen diffusion distance and development of necrosis in multicell spheroids. Radiat Res 79 (1979) 439-453
12. Friedl F., Kimura I., Osato T., and Ito Y. Studies on a new human cell line (SiHa) derived from carcinoma of uterus. I. Its establishment and morphology. Proc Soc Exp Biol Med 135 (1970) 543-545
13. Jankovic B., Aquino-Parsons C., Raleigh J.A., et al. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix. Cytometry B Clin Cytom 70 (2006) 45-55
14. Koch C.J., Kruuv J., and Frey H.E. The effect of hypoxia on the generation time of mammalian cells. Radiat Res 53 (1973) 43-48
15. Koh W., Rasey J.S., Evans M.L., et al. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. Int J Radiat Oncol Biol Phys 22 (1992) 199-212
16. Ljungkvist A.S., Bussink J., Rijken P.F., Raleigh J.A., Denekamp J., and van der Kogel A.J. Changes in tumor hypoxia measured with a double hypoxic marker technique. Int J Radiat Oncol Biol Phys 48 (2000) 1529-1538
17. Olive P.L., and Aquino-Parsons C. Measurement of tumor hypoxia using single-cell methods. Semin Radiat Oncol 14 (2004) 241-248
18. Olive P.L., Chaplin D.J., and Durand R.E. Pharmacokinetics, binding and distribution of Hoechst 33342 in spheroids and murine tumours. Br J Cancer 52 (1985) 739-746
19. Olive P.L., Durand R.E., Raleigh J.A., Luo C., and Aquino-Parsons C. Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia. Br J Cancer 83 (2000) 1525-1531
20. Raleigh J.A., Zeman E.M., Calkins D.P., McEntee M.C., and Thrall D.E. Distribution of hypoxia and proliferation associated markers in spontaneous canine tumors. Acta Oncol 34 (1995) 345-349
21. 14C]misonidazole in multicell spheroids. Radiat Res 101 (1985) 473-479
22. Sham E., and Durand R.E. Cell kinetics and repopulation mechanisms during multifraction irradiation of spheroids. Radiother Oncol 46 (1998) 201-207
23. Sweigert S.E., and Alpen E.L. Dynamics of cell kinetic parameters during 9L spheroid growth. Cell Tissue Kinet 19 (1986) 567-576
24. Varia M.A., Calkins-Adams D.P., Rinker L.H., et al. Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. Gynecol Oncol 71 (1998) 270-277